- Home
- ATOS vs ZJYL Comparison
ATOS vs ZJYL Comparison
Compare ATOS & ZJYL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATOS
- ZJYL
- Stock Information
- Founded
- ATOS 2009
- ZJYL 2006
- Country
- ATOS United States
- ZJYL China
- Employees
- ATOS N/A
- ZJYL N/A
- Industry
- ATOS Biotechnology: Pharmaceutical Preparations
- ZJYL Industrial Specialties
- Sector
- ATOS Health Care
- ZJYL Consumer Discretionary
- Exchange
- ATOS Nasdaq
- ZJYL Nasdaq
- Market Cap
- ATOS 114.5M
- ZJYL 127.4M
- IPO Year
- ATOS 2012
- ZJYL 2023
- Fundamental
- Price
- ATOS $0.80
- ZJYL $0.76
- Analyst Decision
- ATOS Strong Buy
- ZJYL
- Analyst Count
- ATOS 3
- ZJYL 0
- Target Price
- ATOS $7.00
- ZJYL N/A
- AVG Volume (30 Days)
- ATOS 678.1K
- ZJYL 256.9K
- Earning Date
- ATOS 03-31-2025
- ZJYL 01-01-0001
- Dividend Yield
- ATOS N/A
- ZJYL N/A
- EPS Growth
- ATOS N/A
- ZJYL 18.46
- EPS
- ATOS N/A
- ZJYL 0.02
- Revenue
- ATOS N/A
- ZJYL $23,502,010.00
- Revenue This Year
- ATOS N/A
- ZJYL N/A
- Revenue Next Year
- ATOS N/A
- ZJYL N/A
- P/E Ratio
- ATOS N/A
- ZJYL $32.52
- Revenue Growth
- ATOS N/A
- ZJYL 18.57
- 52 Week Low
- ATOS $0.72
- ZJYL $0.70
- 52 Week High
- ATOS $2.31
- ZJYL $11.15
- Technical
- Relative Strength Index (RSI)
- ATOS 41.00
- ZJYL 43.01
- Support Level
- ATOS $0.79
- ZJYL $0.77
- Resistance Level
- ATOS $0.89
- ZJYL $0.90
- Average True Range (ATR)
- ATOS 0.05
- ZJYL 0.09
- MACD
- ATOS 0.01
- ZJYL -0.01
- Stochastic Oscillator
- ATOS 25.14
- ZJYL 1.50
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary innovative medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
About ZJYL JIN MEDICAL INTERNATIONAL LTD.
Jin Medical International Ltd offers rehabilitation equipment. It is engaged in the design, development, manufacturing, and sales of wheelchairs and other living aids products to be used by people with disabilities or impaired mobility. The company's products are sold to distributors in both China and overseas markets. Its product offerings comprise Wheelechaire serirs, Bath products, oxygen machines, and nursing products. Geographically, it generates the majority of its revenue from Japan.